- Home
- IGC vs MKZR Comparison
IGC vs MKZR Comparison
Compare IGC & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- MKZR
- Stock Information
- Founded
- IGC 2005
- MKZR 2012
- Country
- IGC United States
- MKZR United States
- Employees
- IGC N/A
- MKZR N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- MKZR
- Sector
- IGC Health Care
- MKZR
- Exchange
- IGC Nasdaq
- MKZR Nasdaq
- Market Cap
- IGC 29.4M
- MKZR 26.8M
- IPO Year
- IGC N/A
- MKZR N/A
- Fundamental
- Price
- IGC $0.31
- MKZR $1.94
- Analyst Decision
- IGC Strong Buy
- MKZR
- Analyst Count
- IGC 2
- MKZR 0
- Target Price
- IGC $3.88
- MKZR N/A
- AVG Volume (30 Days)
- IGC 392.1K
- MKZR 267.9K
- Earning Date
- IGC 02-18-2025
- MKZR 01-01-0001
- Dividend Yield
- IGC N/A
- MKZR 15.63%
- EPS Growth
- IGC N/A
- MKZR N/A
- EPS
- IGC N/A
- MKZR N/A
- Revenue
- IGC $1,236,000.00
- MKZR $23,087,751.00
- Revenue This Year
- IGC N/A
- MKZR N/A
- Revenue Next Year
- IGC $18.34
- MKZR N/A
- P/E Ratio
- IGC N/A
- MKZR N/A
- Revenue Growth
- IGC 1.64
- MKZR 57.39
- 52 Week Low
- IGC $0.26
- MKZR $1.05
- 52 Week High
- IGC $0.91
- MKZR $5.50
- Technical
- Relative Strength Index (RSI)
- IGC 52.84
- MKZR N/A
- Support Level
- IGC $0.26
- MKZR N/A
- Resistance Level
- IGC $0.34
- MKZR N/A
- Average True Range (ATR)
- IGC 0.02
- MKZR 0.00
- MACD
- IGC 0.01
- MKZR 0.00
- Stochastic Oscillator
- IGC 65.88
- MKZR 0.00
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.